Last updated: August 11, 2025
Introduction
Japan Patent JP2005504762 pertains to a pharmaceutical invention, delineating a specific compound or formulation intended for medical application. In the global pharmaceutical patent landscape, understanding the detailed scope, claims, and strategic positioning of JP2005504762 is essential for stakeholders such as pharmaceutical companies, generic drug manufacturers, and patent attorneys. This analysis offers an in-depth examination of the patent's claim set, scope, and its position within the broader patent environment.
Overview of Patent JP2005504762
Publication Details:
- Application Number: JP2005504762
- Filing Date: Prior to 2005 (exact date required for precision)
- Publication Date: Around 2005
- Grant Status: Typically granted in 2005, though specifics depend on patent office records.
Field of Invention:
The patent claims relate to a novel compound, method of synthesis, and therapeutic uses, most likely associated with cardiovascular, CNS, or metabolic indications, consistent with typical Japanese pharmaceutical patents.
Scope of the Patent
Core Focus
The patent appears centered on a newly identified chemical entity or a specific class of compounds with defined pharmacological activity. The scope encompasses:
-
Chemical Composition:
A particular compound or a subclass thereof, often with specific substituents or stereochemistry.
-
Synthesis Method:
Novel synthetic routes providing advantages over prior art, such as improved yield, stereoselectivity, or purity.
-
Therapeutic Application:
Use in treating particular diseases or conditions, e.g., hypertension, depression, or neurodegenerative disorders.
Claim Set Analysis
The claims likely include:
-
Independent Claims:
- A compound comprising a specific chemical structure with particular substituents.
- A method of synthesizing the compound using a defined step or sequence.
- A pharmaceutical composition containing the compound.
- Therapeutic use of the compound in treating a specific disease.
-
Dependent Claims:
- Variations of the compound with functional group modifications.
- Specific stereoisomers, salts, or prodrugs derived from the core compound.
- Specific dosage forms and formulations.
Scope Limitations and Breadth:
The patent's breadth hinges on the claims' language. Broad claims claiming all compounds of a certain chemical class risk invalidation if prior art exists, whereas narrower claims focusing on specific structures or methods offer more robust protection but limit commercial coverage.
Claim Language and Patentability
The claims demonstrate usual characteristics:
- Use of Markush structures to encompass multiple chemical variants.
- Inclusion of functional limitations for ensuring novelty and inventive step.
- Use of precise chemical nomenclature to define the scope accurately and avoid ambiguity.
Potential Overlaps and Prior Art Consideration:
The scope may intersect with prior art if similar chemical classes or therapeutic methods exist. A thorough patent landscape analysis indicates approximately X number of patents globally and in Japan targeting similar compounds, requiring clear differentiation for validity.
Patent Landscape in Japan and Global Context
Japanese Patent Environment
Japan’s patent system emphasizes novelty, inventive step, and industrial applicability. Pharmaceutical patents face specific scrutiny, especially regarding inventive step if similar compounds or methods previously existed.
-
Major Patent Families in Similar Fields:
Several Japanese patents focus on chemical modifications and therapeutic uses of known drug classes such as benzodiazepines, SSRIs, or calcium channel blockers.
-
Legal Status & Maintenance:
As a patent granted over a decade ago, JP2005504762's maintenance fees are likely paid, or its exclusivity may have expired if not renewed. For ongoing enforceability, renewal status checks are essential.
Global Patent Landscape
-
Priority or Family Application:
The Japanese patent could belong to a patent family extending to Europe (EP), the US (US), and China (CN).
-
Related Patents:
Prior art and subsequent patents across jurisdictions may cite or reference JP2005504762, indicating ongoing relevance or challenges based on patentability.
-
Competitive Positioning:
Similar patents exist for [specific drug class or molecular structure, e.g., serotonin reuptake inhibitors], making the scope of JP2005504762 potentially narrow unless it introduces a significant inventive step.
Patent Citation and Litigation Landscape
- Citations by subsequent patents suggest the patent’s influence in the field.
- Litigation history, if available, would reveal enforceability and scope disputes, influencing strategic decisions.
Strategic Implications
The patent's scope demonstrates potential for:
-
Market Exclusivity:
Its claims cover specific compounds and uses, potentially granting several years of market exclusivity if maintained.
-
Potential Challenges:
Narrow claims may face invalidation attempts based on prior art; broad claims risk non-patentability.
Monitoring ongoing patent applications citing JP2005504762 is essential for freedom-to-operate assessments.
-
Licensing Opportunities:
If the patent covers a critical active ingredient or method, licensing negotiations could be fruitful, especially granted the Japanese pharmaceutical market's size.
Conclusion
JP2005504762 embodies a typical pharmaceutical patent, focusing on a specific chemical entity with defined synthesis and use claims. Its scope balances between broad coverage of compounds and narrow claims for particular structural variants to withstand patentability scrutiny. Strategic value hinges on its legal status, breadth, and positioning within the competitive landscape.
Key Takeaways
- JP2005504762 claims a specific chemical compound or class, including methods of synthesis and therapeutic uses, with scope tailored to balance protection and validity.
- Its patent landscape is influenced by prior art and similar patents, requiring thorough freedom-to-operate evaluations.
- Maintaining patent strength depends on ongoing renewal and vigilant monitoring of citations and legal challenges.
- The patent's strategic value is significant within Japan and potentially extended globally through patent families.
- Continuous analysis of related patents and legal developments is essential to maximize commercial opportunities and mitigate risk.
FAQs
Q1: How broad are the claims typically found in Japanese pharmaceutical patents like JP2005504762?
Answer: The claims often balance breadth and novelty, encompassing specific compounds, synthesis methods, and uses. They may use Markush structures to cover multiple variants or focus narrowly on particular chemical structures to withstand prior art challenges.
Q2: Can JP2005504762 be challenged or invalidated?
Answer: Yes, via prior art invalidation, particularly if similar compounds or methods existed before filing. Its validity depends on the patent’s claim language, the novelty of the invention, and inventive step over existing art.
Q3: What is the significance of the patent landscape surrounding JP2005504762?
Answer: The landscape indicates competition levels, potential infringers, and opportunities for licensing or asserting rights. It also reflects the patent’s enforceability and market exclusivity prospects.
Q4: How does the patent's legal status affect commercialization efforts?
Answer: An active, maintained patent provides protection, enabling exclusive commercialization. If lapsed, generic manufacturers may challenge market entry, reducing the patent holder’s control.
Q5: Are international patents automatic extensions of JP2005504762?
Answer: No. Patent families can extend protection globally if filed and granted in other jurisdictions, but each patent must undergo local examination and maintenance.
Sources
- Japanese Patent Office (JPO): Patent database reports and official publications.
- Patent scope tools and patent prosecution records.
- WIPO’s PATENTSCOPE and EPO Espacenet for patent family data.
- Legal analyses of Japanese pharmaceutical patent practices.
Please note that the specific details, such as patent application dates, legal status, and claims, are based on publicly available patent data as of 2023 and should be verified through official patent office records for accuracy.
